Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States - Additional Analyses

NCT02917057 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02917057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02917057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States - Additional Analyses
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 1, 2015
Completion date
August 1, 2015
Enrollment
6,024 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes